Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023 (CME VIDEOS)
$129.99
New Year Sale!
- 30% OFF for orders above $299! Use code: BEST30
Description
[
Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment centers on the treatment of usual psychiatric patients with emphasis on the difficult to treat or treatment-resistant. Continuing medical education lectures will enhance your ability to choose treatments as you gain an understanding of the interface between psychiatric, neurological, and medical illness.
Â
Legendary faculty review new antipsychotic medications and treatment augmentation, potential new uses for mood stabilizers, the neurobiologic mechanisms of depression and the role of inflammation, the importance of a therapeutic alliance when prescribing psychotropic medications, and more. With this online CME program, you’ll explore current evidence-based and emerging treatments for:
- Schizophrenia and bipolar disorder
- Bipolar and treatment-resistant depression
- TMS and ECT
- Anxiety spectrum and sleep disorders
- PTSD
- Alcohol and substance abuse disorders
- Women’s mental health issues
- Child, adolescent, and geriatric psychopharmacology
Learning Objectives
At the completion of this course, you should be able to:
- Describe lessons learned from genomic sequencing of patients with psychiatric illnesses
- Identify unsolved problems regarding the pharmacologic treatment of schizophrenia and learning more effective treatments
- Describe emerging theories and treatments of bipolar disorder, difficult-to-treat depression, bipolar depression, and anxiety disorder
- Outline the perils and possibilities of psychedelics and ketamine
- Recognize when to utilize ECT and TMS for treatment-resistant depression
- Illustrate emerging treatments for PTSD
- Review sleep disorders commonly comorbid with psychiatric illness, and appropriate use of medications and treatment
- Review interface of medicine and psychiatry with a focus on cancer, cardiovascular disease
- Review the interface of neurology and psychiatry with an emphasis on functional neurological disease, hysteria, movement disorders, pain, OCD and others
- Summarize the use of genetic tests, serum level measurements, and drug combinations in treatment-resistant depression
- Identify the current role of pharmacotherapy in the treatment of substance use disorders including alcohol, opioids, and cannabis
- Review the role of pharmacotherapy in the treatment of psychiatric disorders throughout women’s reproductive lifespan, with a focus on the premenstrual, prenatal, postpartum, and perimenopausal periods
- Examine the latest advances and problems associated with treatment approaches in the child, adolescent, and geriatric populations
TOPICS / SPEAKERS
Lessons Learned from the DNA of Patients with Psychiatric Disorders – Daniel Weinberger, MD
Neurology and Psychiatry Interface – Martin Samuels, MD, DSc (hon)
The Interface of Medical and Psychiatric Disorders – Focus on Cancer and Heart Disease – Charles Nemeroff, MD, PhD
Tackling Unsolved Problems in the Pharmacological Treatment of Schizophrenia – Cognitive Impairment, Negative Symptoms, and Partial Treatment Response – Philip Harvey, PhD
Panel Discussion – Philip Harvey, PhD, Charles Nemeroff, MD, PhD, Martin Samuels, MD, DSc (hon), and Daniel Weinberger, MD
Pharmacological Treatment of Bipolar Disorder – Ross Baldessarini, MD, DSc (hon)
Anxiety – Treat the Symptom or Treat the Disorder When First Line Therapies Fail – Stephen Stahl, MD, PhD, DSc (hon)
Neurobiology and Treatment of Post-traumatic Stress Disorder – Charles Nemeroff, MD, PhD
Panel Discussion – Ross Baldessarini, MD, DSc (hon), Charles Nemeroff, MD, PhD
Psychopharmacologic Treatment of Sleep Disorders – Sogol Javaheri, MD
Treatment Resistant Depression – Stephen Stahl, MD, PhD, DSc (hon)
Psychedelics and Potential Drugs of Abuse as Antidepressants – Alan Schatzberg, MD
Pharmacotherapy of Substance Use Disorders – Roger Weiss, MD
Panel Discussion – Barbara Coffey, MD, MS, Sogol Javaheri, MD, Alan Schatzberg, MD, Stephen Stahl, MD, PhD, DSc (hon), and Roger Weiss, MD
Child and Adolescent Psychopharmacology – Current Treatment for Best Practices – Barbara Coffey, MD, MS
Psychopharmacology Across the Reproductive Lifespan – From Menarche to Menopause – Ariadna Forray, MD
Geriatric Psychopharmacology – Elizabeth Crocco, MD
Panel Discussion – Barbara Coffey, MD, MS, Elizabeth Crocco, MD, and Ariadna Forray, MD
Date of Original Release:Â June 1, 2023
]
